These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer. Mehra R; Tomlins SA; Shen R; Nadeem O; Wang L; Wei JT; Pienta KJ; Ghosh D; Rubin MA; Chinnaiyan AM; Shah RB Mod Pathol; 2007 May; 20(5):538-44. PubMed ID: 17334343 [TBL] [Abstract][Full Text] [Related]
6. Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues. Tu JJ; Rohan S; Kao J; Kitabayashi N; Mathew S; Chen YT Mod Pathol; 2007 Sep; 20(9):921-8. PubMed ID: 17632455 [TBL] [Abstract][Full Text] [Related]
7. Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer. Winnes M; Lissbrant E; Damber JE; Stenman G Oncol Rep; 2007 May; 17(5):1033-6. PubMed ID: 17390040 [TBL] [Abstract][Full Text] [Related]
8. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Tomlins SA; Mehra R; Rhodes DR; Smith LR; Roulston D; Helgeson BE; Cao X; Wei JT; Rubin MA; Shah RB; Chinnaiyan AM Cancer Res; 2006 Apr; 66(7):3396-400. PubMed ID: 16585160 [TBL] [Abstract][Full Text] [Related]
9. TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer. Hermans KG; van Marion R; van Dekken H; Jenster G; van Weerden WM; Trapman J Cancer Res; 2006 Nov; 66(22):10658-63. PubMed ID: 17108102 [TBL] [Abstract][Full Text] [Related]
10. Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer. Barros-Silva JD; Paulo P; Bakken AC; Cerveira N; Løvf M; Henrique R; Jerónimo C; Lothe RA; Skotheim RI; Teixeira MR Neoplasia; 2013 Jul; 15(7):720-6. PubMed ID: 23814484 [TBL] [Abstract][Full Text] [Related]
11. Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer. Mehra R; Tomlins SA; Yu J; Cao X; Wang L; Menon A; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM Cancer Res; 2008 May; 68(10):3584-90. PubMed ID: 18483239 [TBL] [Abstract][Full Text] [Related]
12. Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis. Sandoval GJ; Pulice JL; Pakula H; Schenone M; Takeda DY; Pop M; Boulay G; Williamson KE; McBride MJ; Pan J; St Pierre R; Hartman E; Garraway LA; Carr SA; Rivera MN; Li Z; Ronco L; Hahn WC; Kadoch C Mol Cell; 2018 Aug; 71(4):554-566.e7. PubMed ID: 30078722 [TBL] [Abstract][Full Text] [Related]
13. Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer. Laxman B; Tomlins SA; Mehra R; Morris DS; Wang L; Helgeson BE; Shah RB; Rubin MA; Wei JT; Chinnaiyan AM Neoplasia; 2006 Oct; 8(10):885-8. PubMed ID: 17059688 [TBL] [Abstract][Full Text] [Related]
14. Genetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse models. Linn DE; Bronson RT; Li Z PLoS One; 2015; 10(3):e0120628. PubMed ID: 25780911 [TBL] [Abstract][Full Text] [Related]
15. The discovery of common recurrent transmembrane protease serine 2 (TMPRSS2)-erythroblastosis virus E26 transforming sequence (ETS) gene fusions in prostate cancer: significance and clinical implications. Shah RB; Chinnaiyan AM Adv Anat Pathol; 2009 May; 16(3):145-53. PubMed ID: 19395877 [TBL] [Abstract][Full Text] [Related]
16. FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer. Paulo P; Barros-Silva JD; Ribeiro FR; Ramalho-Carvalho J; Jerónimo C; Henrique R; Lind GE; Skotheim RI; Lothe RA; Teixeira MR Genes Chromosomes Cancer; 2012 Mar; 51(3):240-9. PubMed ID: 22081504 [TBL] [Abstract][Full Text] [Related]
17. A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer. Han B; Mehra R; Dhanasekaran SM; Yu J; Menon A; Lonigro RJ; Wang X; Gong Y; Wang L; Shankar S; Laxman B; Shah RB; Varambally S; Palanisamy N; Tomlins SA; Kumar-Sinha C; Chinnaiyan AM Cancer Res; 2008 Sep; 68(18):7629-37. PubMed ID: 18794152 [TBL] [Abstract][Full Text] [Related]
18. [Frequency and transcript variant analysis of gene fusions between TMPRSS2 and ETS transcription factor genes in prostate cancer]. Dai MJ; Chen LL; Zheng YB; Chen W; Tao ZH; Weng ZL; Wu XL; Li CD; Chen ZG; Chen XD; Shi SB Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(10):669-73. PubMed ID: 18642766 [TBL] [Abstract][Full Text] [Related]
19. Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma. Han B; Mehra R; Suleman K; Tomlins SA; Wang L; Singhal N; Linetzky KA; Palanisamy N; Zhou M; Chinnaiyan AM; Shah RB Mod Pathol; 2009 Sep; 22(9):1176-85. PubMed ID: 19465903 [TBL] [Abstract][Full Text] [Related]
20. ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples. Miyagi Y; Sasaki T; Fujinami K; Sano J; Senga Y; Miura T; Kameda Y; Sakuma Y; Nakamura Y; Harada M; Tsuchiya E Mod Pathol; 2010 Nov; 23(11):1492-8. PubMed ID: 20693979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]